DE69330884T2 - Behandlung von unfruchtbarkeit und steigerung der befruchtungsfähigkeit männlicher säugetiere durch thymosin-peptid und seine antikörper - Google Patents

Behandlung von unfruchtbarkeit und steigerung der befruchtungsfähigkeit männlicher säugetiere durch thymosin-peptid und seine antikörper

Info

Publication number
DE69330884T2
DE69330884T2 DE69330884T DE69330884T DE69330884T2 DE 69330884 T2 DE69330884 T2 DE 69330884T2 DE 69330884 T DE69330884 T DE 69330884T DE 69330884 T DE69330884 T DE 69330884T DE 69330884 T2 DE69330884 T2 DE 69330884T2
Authority
DE
Germany
Prior art keywords
thymosine
fertilizability
antibodies
peptide
improving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69330884T
Other languages
English (en)
Other versions
DE69330884D1 (de
Inventor
K Naz
L Goldstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
George Washington University
Albert Einstein College of Medicine
George Washington University Medical Center
Original Assignee
George Washington University
Albert Einstein College of Medicine
George Washington University Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by George Washington University, Albert Einstein College of Medicine, George Washington University Medical Center filed Critical George Washington University
Publication of DE69330884D1 publication Critical patent/DE69330884D1/de
Application granted granted Critical
Publication of DE69330884T2 publication Critical patent/DE69330884T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/52—Sperm; Prostate; Seminal fluid; Leydig cells of testes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69330884T 1992-11-17 1993-11-05 Behandlung von unfruchtbarkeit und steigerung der befruchtungsfähigkeit männlicher säugetiere durch thymosin-peptid und seine antikörper Expired - Fee Related DE69330884T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97785192A 1992-11-17 1992-11-17
PCT/US1993/010620 WO1994012144A2 (en) 1992-11-17 1993-11-05 Treatment of infertility and enhancement of fertilization capacity in mammalian males

Publications (2)

Publication Number Publication Date
DE69330884D1 DE69330884D1 (de) 2001-11-08
DE69330884T2 true DE69330884T2 (de) 2002-06-06

Family

ID=25525581

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69330884T Expired - Fee Related DE69330884T2 (de) 1992-11-17 1993-11-05 Behandlung von unfruchtbarkeit und steigerung der befruchtungsfähigkeit männlicher säugetiere durch thymosin-peptid und seine antikörper

Country Status (16)

Country Link
US (1) US5585234A (de)
EP (1) EP0668876B1 (de)
JP (1) JP3989531B2 (de)
KR (1) KR100298858B1 (de)
CN (1) CN1153589C (de)
AU (1) AU679952B2 (de)
CA (1) CA2148689C (de)
DE (1) DE69330884T2 (de)
DK (1) DK0668876T3 (de)
ES (1) ES2164696T3 (de)
FI (1) FI113007B (de)
NO (1) NO320944B1 (de)
PH (1) PH31119A (de)
TW (1) TW234692B (de)
WO (1) WO1994012144A2 (de)
ZA (1) ZA938599B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5873298A (en) * 1998-06-23 1999-02-23 Chang; Kwei-Tang Dual-function filter type pot cover
US20030135876A1 (en) * 2002-01-16 2003-07-17 Larry Mobraaten Maintenance of genetic lines using cryopreserved sperm
IT201900016319A1 (it) * 2019-09-13 2021-03-13 Luigina Romani Timosina alfa 1 per l’uso nel trattamento dell’infertilità maschile da esposizione a metalli pesanti.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612365A (en) * 1980-03-25 1986-09-16 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments
EP0056594B1 (de) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunregulierender Wirkung und Thymosin-alpha-1-Fragmente
US4444757A (en) * 1981-11-16 1984-04-24 Research Corporation Use of thymosin as an anti-diabetes and anti-hypertensive disease agent
US4950590A (en) * 1986-01-13 1990-08-21 Board Of Governors Of Wayne State University Method and kit for assay for measurement of serum thymosin alpha1

Also Published As

Publication number Publication date
DK0668876T3 (da) 2001-12-03
ES2164696T3 (es) 2002-03-01
NO951932D0 (no) 1995-05-16
KR950703984A (ko) 1995-11-17
AU5592194A (en) 1994-06-22
CA2148689C (en) 1998-12-29
JP3989531B2 (ja) 2007-10-10
PH31119A (en) 1998-02-23
WO1994012144A3 (en) 1994-07-21
NO320944B1 (no) 2006-02-20
CN1112444A (zh) 1995-11-29
KR100298858B1 (ko) 2001-11-14
CN1153589C (zh) 2004-06-16
DE69330884D1 (de) 2001-11-08
AU679952B2 (en) 1997-07-17
FI952381A (fi) 1995-07-11
NO951932L (no) 1995-05-16
EP0668876B1 (de) 2001-10-04
CA2148689A1 (en) 1994-06-09
TW234692B (de) 1994-11-21
FI113007B (fi) 2004-02-27
FI952381A0 (fi) 1995-05-16
EP0668876A1 (de) 1995-08-30
WO1994012144A2 (en) 1994-06-09
ZA938599B (en) 1994-06-28
US5585234A (en) 1996-12-17
JPH08503705A (ja) 1996-04-23

Similar Documents

Publication Publication Date Title
DE69318433T2 (de) Verfahren zur Behandlung von Verbrennungsabgasen
DE69333706D1 (de) Oberflächenumformung von rodenten Antikörpern
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
KR950700732A (ko) 알러지성 및 염증성 질환의 치료에 유용한 화합물(Compounds useful for treating allergic and inflammatory diseases)
BR9607669A (pt) Derivado de hormõnio de peptídeo e processo de proporcionar o mesmo
DE69330603T2 (de) Verfahren zur Metallisierung und Verbindung bei der Herstellung von Leistungshalbleiterbauelementen
DE69312853T2 (de) Behandlung von Gummiartikeln
ATE286510T1 (de) In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper
DE69317632D1 (de) Verfahren zur Behandlung von Ozonschicht dezimierenden Substanzen
DE69316203T2 (de) Elektrochemische behandlung von oberflächen
DE69331825D1 (de) Zusammensetzungen und methoden der inhibition der beta-proteinfunktion
DE69133144T2 (de) Reaktor zur Behandlung von Wafern
DE69320540D1 (de) Herstellungsverfahren von Verbindungshalbleitern
DE69330884T2 (de) Behandlung von unfruchtbarkeit und steigerung der befruchtungsfähigkeit männlicher säugetiere durch thymosin-peptid und seine antikörper
DE69325141D1 (de) Behandlung von lignozellulosehaltigen Materialien
DE69327312D1 (de) Deazaaminopterine für behandlung von entzündungen
DE69301936T2 (de) Verfahren zur Behandlung von Rauchgas
BR9606753A (pt) Composto para o tratamento de uma doença autoimune e processo de tratamento de uma doença mediada do sistema imune
DE69412178D1 (de) Apparat zur Behandlung von Lagen
DE69306831D1 (de) Behandlung von Flüssigkeiten
DE69327487D1 (de) Herstellungsverfahren von Verbindungshalbleitern
DE69321284D1 (de) Verfahren zur Herstellung von durch Pfropfung modifizierten Copolymerisaten
DE69331549T2 (de) Nachweiss von anti-hpa antikörpern
DE69203707D1 (de) Verfahren zur Reinigung von Fluorethanen und Chlorfluorethanen.
DE69304224D1 (de) Verfahren zur Herstellung von P-Aminophenolen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee